Which patients with extensive stage small-cell lung cancer should and should not receive thoracic radiotherapy?

Mednet Member

Radiation Oncology · Quillen VA Medical Center

The CREST trial did not meet primary goal of improving one year survival, but it did improve 2 year OS. Looking at subset, achieving CR to chemo was an indicator of a group that "did not benefit". So the rest of the question (what volume, what dose etc) becomes irrelevant.